The WHO has published a report this week listing 12 families of antibiotic-resistant bacteria that are thought to pose the greatest public health risk and should be the focus for new treatments.
Researchers have suggested that exposure to Listeria may pose a greater risk of complications in early pregnancy than previously appreciated.
The National Institutes of Health (MD, USA) have begun a Phase I clinical trial examining a vaccine intended to provide broad protection against a range of mosquito-borne diseases by targeting the insect’s saliva.
Researchers have utilized a novel mouse model to demonstrate that Zika infection during early pregnancy could lead to higher risk of miscarriage in addition to thin brain tissue and brain inflammation in infants.
Researchers have demonstrated that nanoparticles, such as those from burning fossil fuels, appear to reactivate latent herpesviruses in lung tissue.
Researchers have demonstrated that a new whole-parasite vaccine could provide up to 100% protection in clinical trials carried out at the University of Tübingen (Germany).
A new meta-analysis has presented findings reporting that regular vitamin D supplementation could drastically lower the risk of acute respiratory infections.
Researchers have suggested that a virion protein known as BNRF1, produced by the Epstein–Barr Virus, may be responsible for tumor formation.
Researchers have suggested that disease “superspreaders” may have been responsible for two-thirds of cases in the West Africa Ebola epidemic. Targeting these individuals could lead to better disease control measures in future outbreaks.